With regard to the funding agreement with Prince Edward Island to improve affordable access to prescription drugs signed on August 11, 2021: (a) does the government have analyses on whether this initiative provides better access to prescription drugs when compared to (i) the recommendations of the Advisory Council on the Implementation of National Pharmacare, (ii) the Cost Estimate of a Single-payer Universal Drug Plan report issued by the Parliamentary Budget Officer on October 13, 2023; (b) what are the details of all analyses in (a); (c) does the government have analyses on whether this initiative would result in better cost savings compared to (i) the recommendations of the Advisory Council on the Implementation of National Pharmacare, (ii) the Cost Estimate of a Single-payer Universal Drug Plan report issued by the Parliamentary Budget Officer on October 13, 2023; and (d) what are the details of all analyses in (c)?
In the House of Commons on January 29th, 2024. See this statement in context.